Berlin Pharmaceutical Association, Berlin, Germany.
Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):141-9. doi: 10.1002/pds.1861.
The purpose of this study was to assess prevalence and characteristics, including safety-relevance, of drug-related problems (DRPs) detectable in community pharmacy routine service, and to investigate the influence of relevant risk factors.
Patients in 69 community pharmacies in Berlin were surveyed using a checklist for quality assurance of DRP detection in order to enable quantitative detection. An expert committee assessed the safety-relevance of detected DRPs by use of an algorithm. Logistic regression analysis was applied to investigate the influence of different risk factors.
Of the 3040 surveyed patients, 638 (21.0%) were affected by DRPs. Among these, 455 (71.3%) had problems of low, 170 (26.6%) of significant and 13 (2.0%) of high safety-relevance. Significant risk factors identified were self-medication and new medication, especially new prescriptions. Age, gender and the number of dispensed drugs had little influence on occurrence of DRPs. The two major groups of DRPs were therapeutic errors, often correlating with self-medication, and information problems, often correlating with new medications. Drug classes most frequently associated with DRPs were analgesics/NSAID, antibiotics, nasal preparations and cough medications.
DRPs are frequent among patients in German community pharmacies. Advanced research in this field (DRP-pharmacovigilance) and implementation of methods for quality assurance of pharmaceutical counselling, that is exhaustive DRP detection, may improve the safety of drug therapies significantly. In particular, pharmaceutical counselling is an important instrument for assuring treatment appropriateness and safety of OTC drugs.
本研究旨在评估社区药房常规服务中可检测到的药物相关问题(DRP)的流行率和特征,包括与安全性相关的问题,并探讨相关风险因素的影响。
在柏林的 69 家社区药房中,使用 DRP 检测质量保证检查表对患者进行调查,以便进行定量检测。一个专家委员会使用算法评估检测到的 DRP 的安全性相关性。应用逻辑回归分析调查了不同风险因素的影响。
在调查的 3040 名患者中,有 638 名(21.0%)受到 DRP 的影响。其中,455 名(71.3%)为低安全性相关问题,170 名(26.6%)为显著安全性相关问题,13 名(2.0%)为高安全性相关问题。确定的显著风险因素是自我用药和新用药,特别是新处方。年龄、性别和配药数量对 DRP 的发生影响不大。DRP 的两个主要类型是治疗错误,常与自我用药相关,以及信息问题,常与新用药相关。与 DRP 最相关的药物类别是镇痛药/非甾体抗炎药、抗生素、鼻腔制剂和咳嗽药物。
德国社区药房的患者中 DRP 很常见。在该领域(DRP-药物警戒)进行高级研究并实施药物咨询质量保证方法,即全面检测 DRP,可能会显著提高药物治疗的安全性。特别是,药物咨询是确保 OTC 药物治疗适当性和安全性的重要手段。